Shane Bohnen - Aug 15, 2023 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Role
SVP - General Counsel
Signature
/s/ Shane Bohnen
Stock symbol
TECH
Transactions as of
Aug 15, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/24/2023, 04:20 PM
Date Of Original Report
Aug 17, 2023
Previous filing
Apr 4, 2023
Next filing
Apr 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TECH Common Stock 135 Aug 15, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Award $0 +148 $0.00 148 Aug 15, 2023 Common Stock 148 Direct F1, F2
transaction TECH Stock Option (Right to Buy) Award $0 +16.3K $0.00 16.3K Aug 15, 2023 Common Stock 16.3K $84.61 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 49 restricted stock units vest on each of 8/15/2024 and 8/15/2026, and 50 restricted stock units vest on 8/15/2025.
F3 This grant was previously reported as options to purchase 15,904 shares. This amendment reflects the corrected number of stock options granted.
F4 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.